| Line Item | 2023-06-30 | Y/Y |
|---|---|---|
| Revenue | $7.38B | -36.7% |
| Cost of Revenue | $6.03B | -26.4% |
| R&D Expense | $797.0M | -15.3% |
| SG&A Expense | $491.0M | -12.2% |
| Operating Income | -$342.0M | -117.5% |
| Interest Expense | $313.0M | +25.7% |
| Pre-tax Income | -$496.0M | -129.5% |
| Income Tax | $33.0M | +10.0% |
| Net Income | -$529.0M |
| Line Item | 2023-06-30 | Y/Y |
|---|---|---|
| Cash & Equivalents | $786.0M | +27.8% |
| Accounts Receivable | $621.0M | -59.5% |
| Inventory | $1.14B | -27.2% |
| Current Assets | $2.90B | -28.0% |
| Total Assets | $7.56B | -15.5% |
| Current Liabilities | $2.59B | -27.1% |
| Long-term Debt | $964.0M | +0.0% |
| Line Item | 2023-06-30 | Y/Y |
|---|---|---|
| Operating Cash Flow | $942.0M | -43.2% |
| Capital Expenditures | $316.0M | -17.1% |
| Investing Cash Flow | $217.0M | +161.6% |
| Financing Cash Flow | -$988.0M | +48.0% |
| Free Cash Flow | $626.0M | -50.9% |
| -132.1% |
| EPS (Basic) | -$2.56 | -134.1% |
| EPS (Diluted) | -$2.56 | -134.8% |
| Total Liabilities |
| $8.76B |
| -0.9% |
| Stockholders' Equity | -$1.20B | -1200.0% |